Advances in Chronic Kidney Disease
Volume 15, Issue 3 , Pages 321-331 , July 2008

Phosphate Levels and Blood Pressure in Incident Hemodialysis Patients: A Longitudinal Study

References 

  1. Agarwal R, Nissenson AR, Batlle D, et al. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med. 2003;115:291–297
  2. HCFA-1995 . Opportunities to improve care for adult in-center hemodialysis patients. Annual Report: ESRD core indicators project. January 19, 1996;
  3. Rahman M, Dixit A, Donley V, et al. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients. Am J Kidney Dis. 1999;33:498–506
  4. Zager PG, Nikolic J, Brown RH, et al. “U” curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int. 1998;54:561–569
  5. Mailloux LU. Hypertension in chronic renal failure and ESRD: Prevalence, pathophysiology, and outcomes. Semin Nephrol. 2001;21:146–156
  6. Giachelli CM, Jono S, Shioi A, et al. Vascular calcification and inorganic phosphate. Am J Kidney Dis. 2001;38:S34–S37
  7. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–2218
  8. Schucker JJ, Ward KE. Hyperphosphatemia and phosphate binders. Am J Health Syst Pharm. 2005;62:2355–2361
  9. O'Neill WC. The fallacy of the calcium-phosphorus product. Kidney Int. 2007;72:792–796
  10. Spalding EM, Chamney PW, Farrington K. Phosphate kinetics during hemodialysis: Evidence for biphasic regulation. Kidney Int. 2002;61:655–667
  11. Lorenzo SV, Torres RA. Management of hyperphosphataemia in dialysis patients: Role of phosphate binders in the elderly. Drugs Aging. 2004;21:153–165
  12. Powe NR, Klag MJ, Sadler JH, et al. Choices for healthy outcomes in caring for end stage renal disease. Semin Dial. 1996;9:9–11
  13. U.S. Renal Data System. U.S. Renal Data System 1999 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institute of Health, National Institute of Diabetes and Digestive and Kidney Disease; 1999;
  14. Greenfield S, Sullivan L, Silliman RA, et al. Principles and practice of case mix adjustment: Applications to end-stage renal disease. Am J Kidney Dis. 1994;24:298–307
  15. Miskulin DC, Meyer KB, Athienites NV, et al. Comorbidity and other factors associated with modality selection in incident dialysis patients: The CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease. Am J Kidney Dis. 2002;39:324–336
  16. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479–486
  17. Unruh ML, Evans IV, Fink NE, et al. Skipped treatments, markers of nutritional nonadherence, and survival among incident hemodialysis patients. Am J Kidney Dis. 2005;46:1107–1116
  18. Delmez JA, Slatopolsky E. Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis. 1992;19:303–317
  19. Huting J. Mitral valve calcification as an index of left ventricular dysfunction in patients with end-stage renal disease on peritoneal dialysis. Chest. 1994;105:383–388
  20. Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol. 2002;39:695–701
  21. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–1483
  22. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int. 2001;60:472–479
  23. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87:E10–E17
  24. Moe SM, O'Neill KD, Duan D, et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int. 2002;61:638–647
  25. Shioi A, Taniwaki H, Jono S, et al. Monckeberg's medial sclerosis and inorganic phosphate in uremia. Am J Kidney Dis. 2001;38:S47–S49
  26. Achinger SG, Ayus JC. Left Ventricular hypertrophy: Is hyperphosphatemia among dialysis patients a risk factor?. J Am Soc Nephrol. 2006;17:S255–S261
  27. Ayus JC, Mizani MR, Achinger SG, et al. Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: A prospective, controlled study. J Am Soc Nephrol. 2005;16:2778–2788
  28. Klassen PS, Lowrie EG, Reddan DN, et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA. 2002;287:1548–1555
  29. Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int. 2006;70:351–357
  30. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1–S201
  31. Guerin AP, London GM, Marchais SJ, et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000;15:1014–1021
  32. Stubbs JR, Liu S, Tang W, et al. Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol. 2007;18:2116–2124
  33. Leggat JE, Orzol SM, Hulbert-Shearon TE, et al. Noncompliance in hemodialysis: Predictors and survival analysis. Am J Kidney Dis. 1998;32:139–145

 Supported by grant no. RO1 DK 59616 from the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, grant no. R01 HS 08365 from the Agency for Health Care Research and Quality, Rockville, Maryland, and grant no. R01 HL 62985 from the National Heart Lung and Blood Institute, Bethesda, MD. Dr. Powe is supported by grant K24 DK 02643 and Dr. Melamed is supported by grant K23-DK078774 from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.

 Some of the data reported here have been supplied by the United States Renal Data System. The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the US government.

PII: S1548-5595(08)00059-1

doi: 10.1053/j.ackd.2008.04.012

Advances in Chronic Kidney Disease
Volume 15, Issue 3 , Pages 321-331 , July 2008

Article Tools

* Image Usage & Resolution